New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding

Pharmacophore-Based Screening and Identification of Novel Human Ligase I Inhibitors with Potential Anticancer Activity

(2014) Shagun Krishna et al.   Journal of Chemical Information and Modeling

Targeting the ‘Janus face' of the B2-bradykinin receptor

(2013) Nelly Blaes et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2receptor antagonist

(2012) A Faussner et al.   BRITISH JOURNAL OF PHARMACOLOGY

Diversity and modularity of G protein-coupled receptor structures

(2011) Vsevolod Katritch et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor

(2010) S Meini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

(2010) B. Wu et al.   SCIENCE

Novel Small Molecule Bradykinin B2Receptor Antagonists

(2009) Christoph Gibson et al.   JOURNAL OF MEDICINAL CHEMISTRY

The Structure of the Neuropeptide Bradykinin Bound to the Human G-Protein Coupled Receptor Bradykinin B2 as Determined by Solid-State NMR Spectroscopy

(2008) Jakob J. Lopez et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Icatibant

(2008) Konrad Bork et al.   NATURE REVIEWS DRUG DISCOVERY